Dosage research.
Summaries of the dose ranges reported in the published preclinical and (where applicable) clinical-trial research literature on each of the 23 catalog compounds. These pages describe what investigators have reported; they do not constitute dosing guidance for any human or animal subject.
Published dose ranges by compound.
-
Dosage research
Dosage research on MOTS-c
-
Dosage research
Dosage research on Epithalon
-
Dosage research
Dosage research on Ipamorelin
-
Dosage research
Dosage research on CJC-1295 No DAC
-
Dosage research
Dosage research on Semaglutide
-
Dosage research
Dosage research on Tirzepatide
- Dosage research
- Dosage research
-
Dosage research
Dosage research on Tesamorelin
-
Dosage research
Dosage research on NAD+
-
Dosage research
Dosage research on 5-Amino-1MQ
-
Dosage research
Dosage research on Selank
-
Dosage research
Dosage research on KPV
-
Dosage research
Dosage research on Semax
-
Dosage research
Dosage research on AOD-9604
-
Dosage research
Dosage research on CJC-1295 + Ipamorelin Blend
-
Dosage research
Dosage research on Wolverine Stack
-
Dosage research
Dosage research on Glow Blend
-
Dosage research
Dosage research on KLOW Blend
-
Dosage research
Dosage research on Bacteriostatic Water
-
Dosage research
Dosage research on BPC-157
-
Dosage research
Dosage research on TB-500
-
Dosage research
Dosage research on GHK-Cu
Research-use-only framing. The dose-range summaries on these pages describe what has been reported in the published preclinical and clinical-trial research literature. They do not constitute medical, veterinary, or clinical advice; they do not recommend any specific dose for any individual; and they are not prescriptions, treatment plans, or dosing guidelines. Every compound described is sold strictly as a research-grade reagent for laboratory and bench-research applications.

